• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ECLIPSE FILTER SYSTEM - FEMORAL VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ECLIPSE FILTER SYSTEM - FEMORAL VENA CAVA FILTER Back to Search Results
Catalog Number EC500F
Device Problems Difficult to Remove (1528); Malposition of Device (2616); Detachment of Device or Device Component (2907); Material Deformation (2976); Patient Device Interaction Problem (4001); Migration (4003)
Patient Problem Pulmonary Embolism (1498)
Event Date 10/04/2012
Event Type  Injury  
Manufacturer Narrative

Manufacturing review: a device history record review could not be performed as the lot number is unknown. Investigation summary: the device was not returned for evaluation. Medical records were provided and reviewed. Approximately six months later, a computed tomogram angiogram of chest was performed for history of shortness of breath. The study showed small linear filling defect in the proximal left upper lobe pulmonary artery that appears to represent possibly an old fibrin clot. On the next day, patient was planned for filter removal. Through the right jugular vein approach, a venogram was performed. Inferior vena cava filter hook ingrown into the inferior vena cava wall and unable to remove the filter. After one year, a computed tomogram angiogram of chest was performed for shortness of breath. The study showed that small amount of thrombus in the lateral aspect of the right and left main pulmonary artery. This extends into the proximal portion of the right and left upper lobe pulmonary arteries and the right and left lower lobe pulmonary arteries. The findings are consistent with pulmonary embolism. After eight months, patient presented with the complaints of shortness of breath. A computed tomography angiogram of chest was performed which showed negative for pulmonary embolism. After seven months, patient presented with the complaints of low back pain and leg pain. Patient was planned for lumbar laminectomy procedure. An x-ray lumbar spine was performed which showed inferior vena cava filter was noted. After three months, an x-ray lumbar spine was performed which showed inferior vena cava filter projects at the l2-l3 level. Filter tilted towards the left side and a fractured strut identified extending cephalad to the tip of the filter. After two months, an x-ray lumbar spine was performed which showed partially visualized inferior vena cava filter which was tilted but unchanged. After one year and eleven months, a computed tomography of abdomen was performed for filter evaluation. The study showed that inferior vena cava filter was noted with the tip roughly at 3 cm inferior to the left renal vein. The filter was tilted to the right with the cone of the filter penetrating through the wall of the inferior vena cava into the pericaval/mesenteric fat. There was a prong bent superiorly and extending outside the medial wall of the inferior vena cava into the retroperitoneum. One of the arms of the filter was fractured off of the filter. It was positioned in the inferior vena cava immediately superior to the cone of the filter and extends through the left lateral wall of the inferior vena cava into the pericaval/mesenteric fat. One of the legs of the filter penetrates through the wall of the inferior vena cava into the mid lumen of the abdominal aorta. Several other legs of the filter have penetrated through the wall of the inferior vena cava into the pericaval/mesenteric fat. Therefore, the investigation is confirmed for the alleged filter limb detachment, perforation of the inferior vena cava, filter migration, material deformation and retrieval difficulties. Additionally, it can be confirmed that the patient experienced pulmonary embolism post deployment. However, the relationship to the filter is unknown. Based on the available information, the definitive root cause is unknown. Labeling review: a review of product labeling documents (e. G. Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.

 
Event Description

It was reported through the litigation process that a vena cava filter was placed and the reason for deployment was not provided. At some time post filter deployment, it was alleged that the filter tilted, migrated, strut detached and perforated the vena cava wall, mesentery and aorta. The device has not been removed after an unsuccessful attempt. The detached strut retained in inferior vena cava. The current status of the patient is unknown.

 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameECLIPSE FILTER SYSTEM - FEMORAL
Type of DeviceVENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key12065489
MDR Text Key258299738
Report Number2020394-2021-80528
Device Sequence Number1
Product Code DTK
Combination Product (Y/N)N
Reporter Country CodeUS
PMA/PMN NumberK093659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type CONSUMER,HEALTH PROFESSIONAL
Reporter Occupation
Type of Report Initial
Report Date 06/25/2021
1 Device Was Involved in the Event
1 Patient Was Involved in the Event
Date FDA Received06/25/2021
Is This An Adverse Event Report? Yes
Is This A Product Problem Report? Yes
Device Operator HEALTH PROFESSIONAL
Device Catalogue NumberEC500F
Device LOT NumberUNKNOWN
Was Device Available For Evaluation? No
Is The Reporter A Health Professional?
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received06/08/2021
Was Device Evaluated By Manufacturer? Device Not Returned To Manufacturer
Is The Device Single Use? Yes
Is this a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient TREATMENT DATA
Date Received: 06/25/2021 Patient Sequence Number: 1
Treatment
CARDIZEM, NITROGLYCERIN AND WARFARIN; OMEPRAZOLE, LASIX AND NORCO; RESTORIL, DICLOFENAC AND PROZAC
-
-